Unjha Formulations Limited (BOM:531762)
20.95
-0.05 (-0.24%)
At close: Apr 17, 2026
Unjha Formulations Market Cap
Unjha Formulations has a market cap or net worth of 93.87 million as of April 17, 2026. Its market cap has decreased by -11.60% in one year.
Market Cap
93.87M
Enterprise Value
77.86M
Revenue
148.12M
Ranking
n/a
PE Ratio
8.99
Stock Price
20.95
Market Cap Chart
Since May 25, 2005, Unjha Formulations's market cap has increased from 51.62M to 93.87M, an increase of 81.86%. That is a compound annual growth rate of 2.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 94.09M | -16.00% |
| Dec 31, 2025 | 112.01M | -17.68% |
| Dec 31, 2024 | 136.07M | 86.43% |
| Dec 29, 2023 | 72.99M | 6.19% |
| Dec 30, 2022 | 68.73M | 42.04% |
| Dec 31, 2021 | 48.39M | 19.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Norris Medicines | 147.51M |
| Desh Rakshak Aushdhalaya | 139.89M |
| Emmessar Biotech & Nutrition | 128.90M |
| Beryl Drugs | 127.00M |
| Colinz Laboratories | 118.02M |
| Shamrock Industrial Company | 115.99M |
| Ortin Global | 106.20M |
| Vivanza Biosciences | 80.00M |